Therapeutic Response of Androgenetic Alopecia After Digital Drug Delivery with Application of Prodew 500®, Nanofactor® aFGF, Nanofactor® VEGF, Copper Peptide®, Prohairin B4®, Capillisil HC® and Arct-Alg®

    November 2021 in “ Revista Ibero-Americana de Humanidades, Ciências e Educação ”
    Mônica Ramos de Freitas, Rossana Cantanhede Farias de Vasconcelos, Jayme de Oliveira Filho
    Image of study
    TLDR The document does not give specific results for hair loss treatment effectiveness.
    The document discusses a study on the therapeutic response of androgenetic alopecia (characterized by the progressive loss of hair follicles due to endocrine factors, genetic predisposition, and various biochemical disorders) after digital drug delivery. The treatment involved the topical application of Prodew 500®, Nanofactor® aFGF, Nanofactor® VEGF, Copper Peptídeo®, Prohairin B4®, Capillisil HC®, and Arct-Alg®. However, the document does not provide specific results or conclusions from the study.
    Discuss this study in the Community →